Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
293.00
+10.80 (3.83%)
At close: Apr 20, 2026

HKG:2526 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Net Income
-43.38-56.12
Depreciation & Amortization
13.637.51
Loss (Gain) From Sale of Assets
-0.180.08
Loss (Gain) From Sale of Investments
2.071.01
Loss (Gain) on Equity Investments
0.10
Stock-Based Compensation
0.16.44
Other Operating Activities
19.214.85
Change in Accounts Receivable
-28.09-1.02
Change in Inventory
4.2-2.44
Change in Accounts Payable
4.19-0.28
Change in Other Net Operating Assets
-1.61-17.43
Operating Cash Flow
-29.78-47.4
Capital Expenditures
-24.2-24.22
Sale of Property, Plant & Equipment
0.24-
Sale (Purchase) of Intangibles
-1.05-
Investment in Securities
23.66-92.84
Other Investing Activities
21-
Investing Cash Flow
19.66-117.06
Short-Term Debt Issued
10-
Total Debt Issued
10-
Long-Term Debt Repaid
-2.73-2.2
Net Debt Issued (Repaid)
7.28-2.2
Issuance of Common Stock
-170.15
Other Financing Activities
-0.47-3.97
Financing Cash Flow
6.81163.98
Net Cash Flow
-3.32-0.47
Free Cash Flow
-53.98-71.61
Free Cash Flow Margin
-76.72%-135.52%
Free Cash Flow Per Share
-0.68-0.94
Cash Interest Paid
0.470.26
Cash Income Tax Paid
0.03-
Levered Free Cash Flow
-63.77-
Unlevered Free Cash Flow
-50.52-
Change in Working Capital
-21.31-21.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.